Robert B. Warner
Publications by Year
Research Areas
Cell death mechanisms and regulation, Cancer therapeutics and mechanisms, Receptor Mechanisms and Signaling, Lung Cancer Research Studies, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation(2002)420 cited
- → Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737(2007)301 cited
- → A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs In vitro and In vivo(2006)146 cited
- → Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent(2002)123 cited
- → Novel sulfonate analogues of combretastatin A-4(2001)52 cited
- Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.(2003)
- → Discovery of a novel class of orally active, non-peptide angiotensin II antagonists(1992)37 cited
- → Second-Generation Peptidomimetic Inhibitors of Protein Farnesyltransferase Demonstrating Improved Cellular Potency and Significant in Vivo Efficacy(1999)37 cited
- → Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase(1999)31 cited
- → Endothelin ET<sub>A</sub> Receptor Antagonist Reduces Myocardial Infarction Induced by Coronary Artery Occlusion and Reperfusion in the Rat(1994)21 cited